help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0050
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blumer, J. B.
Right arrow Articles by Lanier, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blumer, J. B.
Right arrow Articles by Lanier, S. M.
Endocrinology Vol. 149, No. 8 3842-3849
Copyright © 2008 by The Endocrine Society

Activator of G Protein Signaling 3 Null Mice: I. Unexpected Alterations in Metabolic and Cardiovascular Function

Joe B. Blumer, Kevin Lord, Thomas L. Saunders, Alejandra Pacchioni, Cory Black, Eric Lazartigues, Kurt J. Varner, Thomas W. Gettys and Stephen M. Lanier

Department of Pharmacology and Experimental Therapeutics (J.B.B., K.L., E.L., K.J.V., S.M.L.), Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112; Department of Internal Medicine (T.L.S.), Transgenic Animal Model Core, University of Michigan, Ann Arbor, Michigan 48109; Division of Experimental Obesity (C.B., T.W.G.), Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808; Department of Neurosciences (A.P.) and Department of Cell and Molecular Pharmacology and Experimental Therapeutics (J.B.B., S.M.L.), Medical University of South Carolina, Charleston, South Carolina 29425

Address all correspondence and requests for reprints to: Stephen M. Lanier, Ph.D., Colcock Hall, Medical University of South Carolina, Charleston, South Carolina 29425. E-mail: lanier{at}musc.edu.

Activator of G protein signaling (AGS)-3 plays functional roles in cell division, synaptic plasticity, addictive behavior, and neuronal development. As part of a broad effort to define the extent of functional diversity of AGS3-regulated-events in vivo, we generated AGS3 null mice. Surprisingly, AGS3 null adult mice exhibited unexpected alterations in cardiovascular and metabolic functions without any obvious changes in motor skills, basic behavioral traits, and brain morphology. AGS3 null mice exhibited a lean phenotype, reduced fat mass, and increased nocturnal energy expenditure. AGS3 null mice also exhibited altered blood pressure control mechanisms. These studies expand the functional repertoire for AGS3 and other G protein regulatory proteins providing unexpected mechanisms by which G protein systems may be targeted to influence obesity and cardiovascular function.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Sato, Q. Jiao, T. Honda, R. Kurotani, E. Toyota, S. Okumura, T. Takeya, S. Minamisawa, S. M. Lanier, and Y. Ishikawa
Activator of G Protein Signaling 8 (AGS8) Is Required for Hypoxia-induced Apoptosis of Cardiomyocytes: ROLE OF G{beta}{gamma} AND CONNEXIN 43 (CX43)
J. Biol. Chem., November 6, 2009; 284(45): 31431 - 31440.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
G. Shioi, D. Konno, A. Shitamukai, and F. Matsuzaki
Structural Basis for Self-Renewal of Neural Progenitors in Cortical Neurogenesis
Cereb Cortex, July 1, 2009; 19(suppl_1): i55 - i61.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society